Clinical Trial Detail

NCT ID NCT02472275
Title PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer
Recruitment Suspended
Gender male
Phase Phase I
Variant Requirements No
Sponsors Barbara Ann Karmanos Cancer Institute
Indications

prostate adenocarcinoma

Therapies

Leuprolide

Pexidartinib

Goserelin

Degarelix

Age Groups: adult

No variant requirements are available.